Zanamivir
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 21 (4), 267-281
- https://doi.org/10.2165/00002018-199921040-00003
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Zanamivir in the Prevention of Influenza Among Healthy AdultsJama-Journal Of The American Medical Association, 1999
- Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaksVaccine, 1998
- Preclinical Development of Low Toxicity DrugsDrug Safety, 1998
- Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase)Antimicrobial Agents and Chemotherapy, 1994
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Influenza: Quantifying morbidity and mortalityAmerican Journal Of Medicine, 1987
- A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a InfectionThe New England Journal of Medicine, 1982
- Successful treatment of naturally occurring influenza A/USSR/77 H1N1JAMA, 1981